Weekly Newsletter

Dafinchi Weekly Newsletter

The earnings shifts, investor discussions, and market signals worth knowing—summarized in one concise email.

Email address

Delivered every week. Unsubscribe anytime.

Latest Earnings

Highlights Feed Latest Earnings Newsletter Blog Company Finder

Newsletternew My Portfolio Highlights Feed Latest Earnings Annual Reviews Earnings Chat Earnings Coach Keyword Scan Deep Research Company Finder Blog Guides Compare Earnings Shareholder Letter History

Quick Links

MCP — Connect your AI About Us FAQs Contact Us Privacy Policy Cookies Policy Terms and Condition Acceptable Use Policy Data Processing Addendum

Contents

Kiniksa Pharmaceuticals International, plc (KNSA) Q2 2021 Earnings Transcript - Dafinchi AI

KNSA Q2 2021

Release Date: Aug 03, 2021

KNSA (Kiniksa Pharmaceuticals International, plc)

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally. The company offers ...view more

IndustryMedical - Pharmaceuticals

SectorHealthcare

HQLondon, GL

Employees366

Sign in to unlock the full earnings breakdown

Get key highlights, executive quotes, the full transcript, and clear answers to your questions in one place.

What you'll get after signing in:

Stock price performance

Key financial metrics

Top discussion topics

Executive highlights

Full earnings transcript

Ask and get clear answers